LION POINT CAPITAL, LP

PrivateCIK: 1643354
Location

NEW YORK, NY

πŸ“‹ What this filing means

LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $19.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

19
Positions
$19.10M
Total AUM (reported)
3.10M
Total Shares

Allocation by class

TOTAL AUM$19.10M19 positions
COM$12.86M67.3%
COM PAR $.01$2.53M13.3%
COM NEW$2.13M11.1%
ORD SHS CL A$907.9K4.8%
COM SHS$672.6K3.5%

Portfolio Concentration

Top 335.2%4–1039.6%11–2525.2%TOP 1074.8%0%100%
Top 3$6.72M35.2%
4–10$7.55M39.6%
11–25$4.82M25.2%

Top 3 weight

35.2%

Top 10 weight

74.8%

Voting Authority Distribution

Total shares with voting rights: 3.10M

Sole

Full voting authority

3.10M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole19
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings19
Rows:

INSMED INC

SOLE
COM PAR $.01
Shares36.70K
TypeSH
Market value$2.53M
13.27%
Sole
36.70K
Shared
0.00
None
0.00

MILESTONE PHARMACEUTICALS IN

SOLE
COM
Shares1.03M
TypeSH
Market value$2.42M
12.68%
Sole
1.03M
Shared
0.00
None
0.00

GERON CORP

SOLE
COM
Shares500K
TypeSH
Market value$1.77M
9.27%
Sole
500K
Shared
0.00
None
0.00

ARDELYX INC

SOLE
COM
Shares335.40K
TypeSH
Market value$1.70M
8.90%
Sole
335.40K
Shared
0.00
None
0.00

FENNEC PHARMACEUTICALS INC

SOLE
COM
Shares195.70K
TypeSH
Market value$1.24M
6.48%
Sole
195.70K
Shared
0.00
None
0.00

BRIDGEBIO PHARMA INC

SOLE
COM
Shares40.30K
TypeSH
Market value$1.11M
5.79%
Sole
40.30K
Shared
0.00
None
0.00

MINERALYS THERAPEUTICS INC

SOLE
COM
Shares79K
TypeSH
Market value$972.5K
5.09%
Sole
79K
Shared
0.00
None
0.00

KINIKSA PHARMACEUTICALS LTD

SOLE
ORD SHS CL A
Shares45.90K
TypeSH
Market value$907.9K
4.75%
Sole
45.90K
Shared
0.00
None
0.00

BIOHAVEN LTD

SOLE
COM
Shares22.70K
TypeSH
Market value$847.8K
4.44%
Sole
22.70K
Shared
0.00
None
0.00

BENITEC BIOPHARMA INC

SOLE
COM NEW
Shares62K
TypeSH
Market value$783.1K
4.10%
Sole
62K
Shared
0.00
None
0.00

SYNDAX PHARMACEUTICALS INC

SOLE
COM
Shares55K
TypeSH
Market value$727.1K
3.81%
Sole
55K
Shared
0.00
None
0.00

JASPER THERAPEUTICS INC

SOLE
COM NEW
Shares32K
TypeSH
Market value$684.2K
3.58%
Sole
32K
Shared
0.00
None
0.00

AVADEL PHARMACEUTICALS PLC

SOLE
COM SHS
Shares64K
TypeSH
Market value$672.6K
3.52%
Sole
64K
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares10.60K
TypeSH
Market value$672.0K
3.52%
Sole
10.60K
Shared
0.00
None
0.00

BLUEBIRD BIO INC

SOLE
COM NEW
Shares78.91K
TypeSH
Market value$658.1K
3.45%
Sole
78.91K
Shared
0.00
None
0.00

ARCUTIS BIOTHERAPEUTICS INC

SOLE
COM
Shares46.30K
TypeSH
Market value$645.0K
3.38%
Sole
46.30K
Shared
0.00
None
0.00

REGENXBIO INC

SOLE
COM
Shares57.75K
TypeSH
Market value$446.4K
2.34%
Sole
57.75K
Shared
0.00
None
0.00

SERES THERAPEUTICS INC

SOLE
COM
Shares340.76K
TypeSH
Market value$283.2K
1.48%
Sole
340.76K
Shared
0.00
None
0.00

SPRUCE BIOSCIENCES INC

SOLE
COM
Shares75K
TypeSH
Market value$31.5K
0.16%
Sole
75K
Shared
0.00
None
0.00
LION POINT CAPITAL, LP 13F Holdings β€” 19 Positions | Finecho